αIIbβ3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium

被引:13
作者
Melis, E
Bonnefoy, A
Daenens, K
Yamamoto, H
Vermylen, J
Hoylaerts, MF
机构
[1] Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium
[2] Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki, Kanagawa, Japan
关键词
platelets; restenosis; subendothelium; thrombosis; vessel injury;
D O I
10.1111/j.1538-7836.2004.00747.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets adhering to blood vessels promote coagulation and inflammation. and release growth factors that trigger smooth muscle cell activation. We have therefore studied the pharmacological modification of platelet deposition quantitatively by comparing adhesion of flowing platelets to various subendothelial ligands in the absence or presence of an antialphaIIbbeta3 antagonist with the effects of antiadhesive treatment consisting of von Willebrand factor (VWF) and fibronectin neutralization or of the combined inhibition of platelet adhesion and aggregation. In vitro, perfusion of anticoagulated human blood over calf skin collagen reiterated that alphaIIbbeta antagonism prevents platelet aggregation, but not adhesion per se: single platelets strongly bound to collagen at wall shear rates of both 1300 and 2700 s(-1), largely VWF-independent. When perfused over a human umbilical vein endothelial cell-derived extracellular matrix, single alphaIIbbeta(3)-antagonized platelets primarily adhered to matrix-bound VWF when perfused at 2700 s(-1) but at 1300 s(-1) they also adhered significantly to fibronectin. During perfusion of anticoagulated rabbit blood over de-endothelialized rabbit aorta at a wall shear rate of 1100 s(-1), alphaIIbbeta, antagonism even increased the absolute numbers of adhering platelets and VWF neutralization redirected alphaIIbbeta(3)-antagonized platelets towards other vascular ligands. Finally, in vivo, following photochemically induced blood vessel injury in mice, alphaIIbbeta(3) antagonism inhibited platelet-rich thrombus formation, but platelet adhesion was only significantly inhibited when associated with fibronectin neutralization. In conclusion, antiadhesive platelet treatment more potently interferes with platelet deposition on injured blood vessels than alphaIIbbeta(3) antagonism, but abrogating platelet adhesion can only be achieved by carefully selected antiplatelet drug combinations.
引用
收藏
页码:993 / 1002
页数:10
相关论文
共 46 条
[1]   Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth - An ex vivo capillary perfusion chamber study in the guinea pig [J].
Andre, P ;
Arbeille, B ;
Drouet, V ;
Hainaud, P ;
Sollier, CBD ;
Caen, JP ;
Drouet, LO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :56-63
[2]  
BADIMON L, 1987, J LAB CLIN MED, V110, P706
[3]   Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen [J].
Barnes, CS ;
Krafft, B ;
Frech, M ;
Hofmann, UR ;
Papendieck, A ;
Dahlems, U ;
Gellissen, G ;
Hoylaerts, MF .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (04) :337-347
[4]  
Barnes M J, 1998, Curr Opin Hematol, V5, P314, DOI 10.1097/00062752-199809000-00002
[5]  
BASTIDA E, 1987, BLOOD, V70, P1437
[6]  
Beumer, 2000, Arterioscler Thromb Vasc Biol, V20, pE16
[7]   Scientific and therapeutic advances in antiplatelet therapy [J].
Bhatt, DL ;
Topol, EJ .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :15-28
[8]   Fluid mechanics of arterial stenosis: Relationship to the development of mural thrombus [J].
Bluestein, D ;
Niu, LJ ;
Schoephoerster, RT ;
Dewanjee, MK .
ANNALS OF BIOMEDICAL ENGINEERING, 1997, 25 (02) :344-356
[9]   Shielding the front-strand β3 of the !von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibα [J].
Bonnefoy, A ;
Yamamoto, H ;
Thys, C ;
Kito, M ;
Vermylen, J ;
Hoylaerts, MF .
BLOOD, 2003, 101 (04) :1375-1383
[10]  
BONNEFOY A, 2003, EXPERT REV CARDIOVAS, V1, P89